Cyclophosphamide in dermatology.

Area of Science:

• Immunology
• Dermatology
• Pharmacology

Background:

• Cyclophosphamide is a chemotherapy drug with potent immunosuppressive properties.
• It is widely used for malignancies and severe autoimmune diseases.
• Pulsed intravenous regimens reduce toxicity compared to oral or high-dose chemotherapy.

Purpose of the Study:

• To review the current literature on cyclophosphamide.
• To explore its clinical applications in dermatology.
• To highlight its potential as an underutilized treatment modality.

Main Methods:

• Literature review of clinical applications of cyclophosphamide.
• Analysis of efficacy and toxicity profiles in various medical fields.
• Focus on dermatological studies and case reports.

Main Results:

• Cyclophosphamide demonstrates significant efficacy in treating severe autoimmune conditions.
• Pulsed i.v. regimens are associated with lower adverse effects in rheumatology.
• Dermatological applications remain relatively underused despite its immunosuppressive potential.

Conclusions:

• Cyclophosphamide is a viable, potent immunosuppressive agent for severe autoimmune dermatoses.
• Optimized administration (e.g., pulsed i.v.) can mitigate toxicity concerns.
• Further research and clinical adoption in dermatology are warranted.